Given the important, albeit contrasting, role of CD9 in breast cancer progression to metastatic disease, this study also sought to determine the effect of Cd9 ablation on breast cancer initiation, growth, and progression to metastasis in vivo. Here, CD9 is linked to metastatic neoplasm.